Abstract
Background: Serum amyloid A protein (SAA) is both an inflammatory factor and an apolipoprotein. However, the relation between genetic polymorphisms of SAA and cerebral infarction (CI) remains unclear. Methods and results. The previously reported 4 Single Nucleotide Polymorphisms (rs12218, rs4638289, rs7131332, and rs11603089) of SAA1 gene were genotyped by TaqMan method in a case-control study including 287 cerebral infarction patients and 376 control subjects. We found rs12218 CC genotype and rs7131332 AA genotype were more frequent among CI patients than among controls (9.76% versus 3.19%, P = 0.001; 32.75% versus 24.20%; p = 0.017; respectively). After adjustment of confounding factors such as sex, age, smoking, drinking, hypertension, diabetes, and lipids profile, the difference remained significant in rs12218 (P < 0.01, OR = 2.106, 95% CI: 1.811-7.121). Conclusion: Genetic polymorphism of SAA1 may be a genetic maker of cerebral infarction in Chinese. © 2013 Zhang et al.; licensee BioMed Central Ltd.
Author supplied keywords
Cite
CITATION STYLE
Zhang, L. J., Yuan, B., Li, H. H., Tao, S. B., Yan, H. Q., Chang, L., & Zhao, J. H. (2013). Associations of genetic polymorphisms of SAA1 with cerebral infarction. Lipids in Health and Disease, 12(1). https://doi.org/10.1186/1476-511X-12-130
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.